Pralatrexate in patients with relapsed or refractory peripheral T-cell lymphoma: results from the pivotal PROPEL study

Peripheral T-cell lymphoma (PTCL) is a poor prognosis subtype of non-Hodgkin's lymphoma with no accepted standard of care. This study evaluated the efficacy and tolerability of pralatrexate, a novel antifolate with promising activity. Patients with independently confirmed PTCL who progressed fo...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Journal of clinical oncology Ročník 29; číslo 9; s. 1182
Hlavní autoři:	O'Connor, Owen A, Pro, Barbara, Pinter-Brown, Lauren, Bartlett, Nancy, Popplewell, Leslie, Coiffier, Bertrand, Lechowicz, Mary Jo, Savage, Kerry J, Shustov, Andrei R, Gisselbrecht, Christian, Jacobsen, Eric, Zinzani, Pier Luigi, Furman, Richard, Goy, Andre, Haioun, Corinne, Crump, Michael, Zain, Jasmine M, Hsi, Eric, Boyd, Adam, Horwitz, Steven
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	United States 20.03.2011
Témata:	Adult Aged Aged, 80 and over Aminopterin - analogs & derivatives Aminopterin - therapeutic use Drug Resistance, Neoplasm - drug effects Female Folic Acid Antagonists - therapeutic use Humans International Agencies Lymphoma, T-Cell, Peripheral - drug therapy Lymphoma, T-Cell, Peripheral - pathology Male Middle Aged Neoplasm Recurrence, Local - drug therapy Neoplasm Recurrence, Local - pathology Prospective Studies Remission Induction Salvage Therapy Standard of Care Survival Rate Treatment Outcome Young Adult
ISSN:	1527-7755, 1527-7755
On-line přístup:	Zjistit podrobnosti o přístupu
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!